Ekso Bionics Holdings, Inc.
EKSONASDAQHealthcare
$11.80
+$0.15(+1.29%)
Market Cap$28625502
P/E Ratio—
52W High$13.5
52W Low$2.73
Ekso Bionics Holdings, Inc. (EKSO) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · EKSO · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $12.80M | $17.93M | $18.28M | $12.91M | $11.25M |
| Cost of Revenue | $5.95M | $8.41M | $9.20M | $6.70M | $4.50M |
| Gross Profit | $6.84M | $9.51M | $9.08M | $6.21M | $6.75M |
| Gross Margin %(computed) | 53.48% | 53.06% | 49.67% | 48.13% | 60.01% |
| Operating Expenses | |||||
| R&D Expenses | $3.03M | $3.87M | $5.03M | $3.63M | $2.75M |
| G&A Expenses | $9.99M | $8.79M | $10.69M | $10.99M | $10.52M |
| Total Operating Expenses | $20.17M | $19.97M | $24.19M | $21.77M | $20.58M |
| Operating Income | ($13.33M) | ($10.46M) | ($15.11M) | ($15.56M) | ($13.83M) |
| Operating Margin %(computed) | -104.12% | -58.35% | -82.67% | -120.48% | -122.96% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.31M | $0.27M | $0.30M | $0.16M | $0.11M |
| Income Before Tax | ($11.70M) | ($11.33M) | ($15.20M) | ($15.08M) | ($9.76M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($11.70M) | ($11.33M) | ($15.20M) | ($15.08M) | ($9.76M) |
| Net Margin %(computed) | -91.37% | -63.21% | -83.14% | -116.79% | -86.82% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-4.91 | $-8.43 | $-16.44 | $-17.45 | $-12.01 |
| Wtd Avg Shares | 2.43M | 1.34M | 0.92M | 0.86M | 0.81M |
| EBITDA | ($9.81M) | ($9.45M) | ($13.20M) | ($14.04M) | ($9.09M) |
| EBITDA Margin %(computed) | -76.67% | -52.74% | -72.20% | -108.71% | -80.83% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Ekso Bionics Holdings, Inc. data
About Ekso Bionics Holdings, Inc. (EKSO) Income Statement
Ekso Bionics Holdings, Inc. (EKSO) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, EKSO reported revenue of $0.01B, gross profit of $0.01B (gross margin 53.48%), and net income of ($0.01B) — a net profit margin of -91.37%.
Frequently asked questions
EKSO · 4 questionsEkso Bionics Holdings, Inc. (EKSO) reported revenue of $0.01B for 2025, down 28.6% year-over-year.
EKSO revenueEKSO salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09